ClinicalTrials.gg
Active, not recruitingNCT06778785Updated Feb 17, 2025

Game-Based Digital Intervention for Depression in Adolescents

An interventional study of Digital Intervention and Health Education in Depression and Anxiety, sponsored by Adai Technology (Beijing) Co., Ltd.. Active, not recruiting at 1 site in China. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-02-17.

Sponsored by Adai Technology (Beijing) Co., Ltd. · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Apr 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the effectiveness of digital interventions in treating depression and anxiety in adolescents. The main question it aims to answer is: Can digital interventions effectively alleviate symptoms of depression and anxiety in adolescents? The trial will include a comparison group where researchers will compare the effects of the digital intervention to traditional health education methods to assess their relative efficacy.

Participants will be asked to engage with the digital intervention platform for a period of two months.

02

Conditions studied

  • Depression
  • Anxiety
03

In context

Depression

8,245 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 450 is above the median of 84 across 6,869 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Adai Technology (Beijing) Co., Ltd. is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) will be used to assess participants' eligibility based on the diagnostic criteria for depression outlined in the DSM-5(the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition).
  • no prior use of antidepressants or antipsychotic medications.
  • having a HAMD (Hamilton Depression scale) score >= 8 upon enrollment
  • demonstrate normal cognitive function.
  • voluntarily agree to participate in the study, and both they and their legal guardians must provide informed consent.
  • being able to read and typeset Chinese.

Exclusion criteria

Exclusion Criteria:

  • with severe consciousness disorders and a history of psychiatric illness, traumatic brain injury, substance dependence, or acute poisoning
  • with concurrent psychiatric disorders (as determined by clinical assessment)
  • at high risk of suicide
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
450 participants (actual)

Study arms

  • Experimental
    Personalized Digital Intervention (Smartphone App-based)

    Behavioral: Digital Intervention · Other: Personalization Algorithm

  • Placebo comparator
    Health Education Placebo (Smartphone App-based)

    Behavioral: Health Education

  • Active comparator
    Non-personalized Digital Intervention (Smartphone App-based)

    Behavioral: Digital Intervention

Interventions

  • BehavioralDigital Intervention

    game-based digital intervention app

  • BehavioralHealth Education

    traditional health education app

  • OtherPersonalization Algorithm

    a proprietary algorithm that adaptively adjust the treatment module and parameters to personalize the treatment regime

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Depression on the 50-point 16-item Hamilton Depression Rating Scale (HAM-D) at Week 8

    HAM-D is a clinician-administered depression assessment scale. To adapt to adolescent participants, item 14 (genital symptoms) was removed. Thus, the score was calculated based on the 16 items. Possible scores range from 0 (no symptoms) to 50 (worst symptom). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  2. Response Rate - 50 Percent or Greater Reduction in the 50-point 16-item Hamilton Depression Rating Scale (HAM-D) at Week 8

    HAM-D is a clinician-administered depression assessment scale. To adapt to adolescent participants, item 14 (genital symptoms) was removed. Thus, the score was calculated based on the 16 items. Possible scores range from 0 (no symptoms) to 50 (worst symptom). The response rate was defined as the number of participants with a 50% or greater reduction in HAM-D score from baseline to week 8.

    Time frame: baseline and immediately after 8-week intervention

Secondary outcomes

  1. Change from Baseline in ADHD on the 54-point 18-item ADHD Rating Scale-IV

    ADHD RS IV is a clinician-administered ADHD assessment scale. Possible scores range from 0 (no symptoms) to 50 (worst symptom). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  2. Change from Baseline in the 7-point Clinical Global Impressions-Severity Scale (CGI-S)

    CGI-S is a clinician-administered symptom severity scale. Possible scores range from 1 (least severe) to 7 (most severe). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  3. Change from Baseline in the 88-point 22-item Ruminative Responses Scale (RRS)

    Rumination is the process of compulsively focused attention on the symptoms of one's distress, and on its possible causes and consequences, as opposed to its solutions. RRS is a self-report scale that measures rumination. Possible scores range from 22 (least ruminative symptoms) to 88 (worst ruminative symptoms). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  4. Change from Baseline in the 35-point 5-item Satisfaction with Life Scale (SWLS)

    The SWLS is a short 5-item instrument designed to measure global cognitive judgments of satisfaction with one's life. Possible scores range from 5 (lowest satisfaction) to 35 (highest satisfaction). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  5. The 7-point Clinical Global Impressions-Improvement Scale (CGI-I)

    CGI-S is a clinician-administered total improvement scale. Possible scores range from 1 (very much improved) to 7 (Very much worse).

    Time frame: immediately after 8-week intervention

  6. Change from Baseline in Anxiety on the 52-point 13-item Hamilton Anxiety Rating Scale (HAM-A) at Week 8

    HAM-A is a clinician-administered anxiety assessment scale. To adapt to adolescent participants, item 12 (genitourinary symptoms) was removed. Thus, the score was calculated based on the 13 items. Possible scores range from 0 (no symptoms) to 52 (worst symptom). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  7. Response Rate - 50 Percent or Greater Reduction in the 52-point 13-item Hamilton Anxiety Rating Scale (HAM-A) at Week 8

    HAM-A is a clinician-administered anxiety assessment scale. To adapt to adolescent participants, item 12 (genitourinary symptoms) was removed. Thus, the score was calculated based on the 13 items. Possible scores range from 0 (no symptoms) to 52 (worst symptom). Change = (Week 8 Score - Baseline Score). The response rate was defined as the number of participants with a 50% or greater reduction in HAM-D score from baseline to week 8.

    Time frame: baseline and immediately after 8-week intervention

Other outcomes

  1. Change from Baseline in Chinese Exam Score at Week 8.

    The Chinese exam score was obtained by asking the participants the score (standardized to a 100-point scale) of their most recent exam on the subject of Chinese taken at school. Possible scores range from 0 (worst academic performance) to 100 (best academic performance). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  2. Change from Baseline in Math Exam Score at Week 8.

    The Math exam score was obtained by asking the participants the score (standardized to a 100-point scale) of their most recent exam on the subject of Math taken at school. Possible scores range from 0 (worst academic performance) to 100 (best academic performance). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

  3. Change from Baseline in English Exam Score at Week 8.

    The English exam score was obtained by asking the participants the score (standardized to a 100-point scale) of their most recent exam on the subject of English taken at school. Possible scores range from 0 (worst academic performance) to 100 (best academic performance). Change = (Week 8 Score - Baseline Score).

    Time frame: baseline and immediately after 8-week intervention

07

Study locations

1 site
  • West China Hospital
    Chengdu, Sichuang, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2024 to primary completion in Dec 2024, 8 months.

Of 3,016 non-industry interventional studies with no phase under Depression, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 8 months is below that.

Counting every sponsor, half of 3,112 studies reached it within 22 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2025
First posted
Jan 16, 2025
StartActual
Apr 17, 2024
Primary completionActual
Dec 30, 2024
CompletionEst.
Jul 1, 2025
Last update
Feb 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06778785
Lead sponsor
Adai Technology (Beijing) Co., Ltd.
Responsible party
Sponsor
First posted
Jan 16, 2025
Start date
Apr 17, 2024
Primary completion
Dec 30, 2024
Completion
Jul 1, 2025 (estimated)
Last update
Feb 17, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion